Search
for
Sort by
Research 331–360 of 1000+
- The Safety of Testosterone Therapy in Women
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- Planar Proton Minibeam Irradiation Elicits Spatially Confined DNA Damage in a Human Epidermis Model
- How safe is prescribing oral minoxidil in patients allergic to topical minoxidil?
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Drug Treatment for Androgenetic Alopecia: First Italian Questionnaire Survey on What Dermatologists Think about Finasteride
- Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
- The postfinasteride syndrome; an overview
- Androgens and the Menopause
- Loose anchoring of anagen hairs and pili torti due to erlotinib
- Delayed onset perforating folliculitis associated with sorafenib
- Hypertrichosis of the pinnae in a patient using panitumumab
- A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- Adverse effects of platelet-rich plasma and microneedling
- Mechanism of Action of Isotretinoin
- Topical minoxidil. A survey of use and complications
- Sodium valproate-aggravated psoriasiform eruption
- Patient preferences in the treatment of alopecia areata: A review of the literature
- Synthesis and Actions of 5α-Reduced Metabolites of Testosterone in the Nervous System
- Perampanel‐induced hair curling in a patient with epilepsy associated with Pitt Hopkins syndrome
- Many sexual adverse effects of finasteride are attributable to a nocebo effect
- Defining the short-term and long-term skin manifestations of COVID-19: insights after more than three years of the pandemic
- Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia
- 5α-Reductase inhibitors in men aged 50 years or older with androgenetic alopecia: A retrospective study
- SAFETY AND TOLERABILITY OF ANTIEPILEPTIC DRUGS AT WOMEN WITH EPILEPSY (DATA OF SVT. LUKA’S INSTITUTE OF CHILD NEUROLOGY AND EPILEPSY)
- DUTASTERIDA ORAL VERSUS FINASTERIDA ORAL NO TRATAMENTO DA ALOPECIA ANDROGENÉTICA MASCULINA: META-ANÁLISE DE EFICÁCIA E PERFIL DE EFEITOS ADVERSOS SEXUAIS
- KRDQN: An Interpretable Prediction Framework for Adverse Drug Reactions via Knowledge–Graph Reinforced Deep Q-Learning
- No Association between Patient Demographics and Adverse Effects of Low-Dose Oral Minoxidil in a Retrospective Cohort study of Nonscarring Alopecia Patients
- The Hidden Epidemic of Topical Steroid Use: Prevalence and Impact Among Jordan’s General Population